BCLI Brainstorm Cell Therapeutics Inc

Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.

$3.68  +0.35 (10.51%)
As of 12/06/2021 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/31/2003
Outstanding shares:  36,277,953
Average volume:  419,084
Market cap:   $120,805,583
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    10501E201
ISIN:        US10501E2019
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   5.36
PS ratio:   0.00
Return on equity:   -120.69%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy